Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sung Hoon Sim

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
BMC Cancer|April 9, 2014
P21 and CD166 as predictive markers of poor response and outcome after fluorouracil-based chemoradiotherapy for the patients with rectal cancerSung Hoon Sim, Mi-Hyun Kang, Yu Jung Kim, et al.
BMC Cancer|March 2, 2016
Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasisSoojin Cha, Jeongeun Lee, Jong-Yeon Shin, et al.
The American Journal of Pathology|March 13, 2017
Novel JAK3-Activating Mutations in Extranodal NK/T-Cell Lymphoma, Nasal TypeSung Hoon Sim, Soyeon Kim, Tae Min Kim, et al.
Cancers|September 28, 2023
Clinicopathological Factors Associated with Oncotype DX Risk Group in Patients with ER+/HER2- Breast CancerRan Song, Dong-Eun Lee, Eun-Gyeong Lee, et al.
International Journal of Molecular Sciences|October 29, 2025
Inhibiting Fatty Acid Oxidation Suppresses Acquired Resistance to Standard Chemotherapy in MelanomaWonyoung Choi, Woojin Ham, Jeong Hwan Park, et al.
Cancer Research and Treatment|June 13, 2023
Establishment of Patient-Derived Organoids Using Ascitic or Pleural Fluid from Cancer PatientsWonyoung Choi, Yun-Hee Kim, Sang Myung Woo, et al.
Frontiers in Oncology|March 22, 2021
The Role of Chemotherapy in Patients With HER2-Negative Isolated Locoregional Recurrence of Breast Cancer: A Multicenter Retrospective Cohort StudyKyoungmin Lee, Sung Hoon Sim, Eun Joo Kang, et al.
Cancer Research and Treatment|September 13, 2022
Androgen Receptor as a Predictive Marker for Pathologic Complete Response in Hormone Receptor-Positive and HER-2-Negative Breast Cancer with Neoadjuvant ChemotherapyEun-Gyeong Lee, Dong-Eun Lee, Hyun Hee Kim, et al.
BMC Cancer|March 3, 2009
The role of PET/CT in detection of gastric cancer recurrenceSung Hoon Sim, Yu Jung Kim, Do-Youn Oh, et al.
Breast Cancer (Dove Medical Press)|April 21, 2023
Progranulin and Breast Cancer Mortality: 13-Year Follow-Up of a Cohort StudyDong-Hoe Koo, Keun Seok Lee, Sung Hoon Sim, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
BMC Cancer|April 9, 2014
P21 and CD166 as predictive markers of poor response and outcome after fluorouracil-based chemoradiotherapy for the patients with rectal cancerSung Hoon Sim, Mi-Hyun Kang, Yu Jung Kim, et al.
BMC Cancer|March 2, 2016
Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasisSoojin Cha, Jeongeun Lee, Jong-Yeon Shin, et al.
The American Journal of Pathology|March 13, 2017
Novel JAK3-Activating Mutations in Extranodal NK/T-Cell Lymphoma, Nasal TypeSung Hoon Sim, Soyeon Kim, Tae Min Kim, et al.
Cancers|September 28, 2023
Clinicopathological Factors Associated with Oncotype DX Risk Group in Patients with ER+/HER2- Breast CancerRan Song, Dong-Eun Lee, Eun-Gyeong Lee, et al.
International Journal of Molecular Sciences|October 29, 2025
Inhibiting Fatty Acid Oxidation Suppresses Acquired Resistance to Standard Chemotherapy in MelanomaWonyoung Choi, Woojin Ham, Jeong Hwan Park, et al.
Cancer Research and Treatment|June 13, 2023
Establishment of Patient-Derived Organoids Using Ascitic or Pleural Fluid from Cancer PatientsWonyoung Choi, Yun-Hee Kim, Sang Myung Woo, et al.
Frontiers in Oncology|March 22, 2021
The Role of Chemotherapy in Patients With HER2-Negative Isolated Locoregional Recurrence of Breast Cancer: A Multicenter Retrospective Cohort StudyKyoungmin Lee, Sung Hoon Sim, Eun Joo Kang, et al.
Cancer Research and Treatment|September 13, 2022
Androgen Receptor as a Predictive Marker for Pathologic Complete Response in Hormone Receptor-Positive and HER-2-Negative Breast Cancer with Neoadjuvant ChemotherapyEun-Gyeong Lee, Dong-Eun Lee, Hyun Hee Kim, et al.
BMC Cancer|March 3, 2009
The role of PET/CT in detection of gastric cancer recurrenceSung Hoon Sim, Yu Jung Kim, Do-Youn Oh, et al.
Breast Cancer (Dove Medical Press)|April 21, 2023
Progranulin and Breast Cancer Mortality: 13-Year Follow-Up of a Cohort StudyDong-Hoe Koo, Keun Seok Lee, Sung Hoon Sim, et al.
Pageof 8